Inhibition of interleukin-13 gene expression by triptolide in activated T lymphocytes

Respirology

Volumn 18, Issue 8, 2013, Pages 1249-1255

  Dai, Shanlin ^a   Yin, Kaisheng ^a   Yao, Xin ^a   Zhou, Lin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

GATA3; interleukin 13; nuclear factor of activated T cells; nuclear translocation; triptolide

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 13; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT; TRIPTOLIDE;

ARTICLE; ASTHMA; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

GATA3; INTERLEUKIN-13; NUCLEAR FACTOR OF ACTIVATED T CELLS; NUCLEAR TRANSLOCATION; TRIPTOLIDE;

CELL LINE; CELLS, CULTURED; DITERPENES; EPOXY COMPOUNDS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-13; NFATC TRANSCRIPTION FACTORS; PHENANTHRENES; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 84886818944     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12145     Document Type: Article

References (31)

1. Nguyen TH, Casale TB,. Immune modulation for treatment of allergic disease. Immunol. Rev. 2011; 242: 258-271.
2. Maziak W,. The Th1-Th2 paradigm and asthma: how far should we go? J. Asthma 2003; 40: 201-205.
3. Laoukili J, Perret E, Willems T, et al. IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J. Clin. Invest. 2001; 108: 1817-1824.
4. Yamashita N, Tashimo H, Ishida H, et al. Involvement of GATA-3-dependent Th2 lymphocyte activation in airway hyperresponsiveness. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006; 290: L1045-1051.
5. Laporte JC, Moore PE, Baraldo S, et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am. J. Respir. Crit. Care Med. 2001; 164: 141-148.
6. Booth BW, Sandifer T, Martin EL, et al. IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir. Res. 2007; 8: 51-62.
7. Bartram U, Speer CP,. The role of transforming growth factor beta in lung development and disease. Chest 2004; 125: 754-765.
8. Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-2261.
9. Wilson MS, Elnekave E, Mentink-Kane MM, et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J. Clin. Invest. 2007; 117: 2941-2951.
10. Blanchard C, Mishra A, Saito-Akei H, et al. Inhibition of human interleukin-13-induced respiratory and oesophageal inflammation by anti-human-interleukin-13 antibody (CAT-354). Clin. Exp. Allergy 2005; 35: 1096-1103.
11. Hirst SJ, Hallsworth MP, Peng Q, et al. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am. J. Respir. Crit. Care Med. 2002; 165: 1161-1171.
12. Kishikawa H, Sun J, Choi A, et al. The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J. Immunol. 2001; 167: 4414-4420.
13. Macian F,. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 2005; 5: 472-484.
14. Mao H, Chen XR, Yi Q, et al. Mycophenolate mofetil and triptolide alleviating airway inflammation in asthmatic model mice partly by inhibiting bone marrow eosinophilopoiesis. Int. Immunopharmacol. 2008; 8: 1039-1048.
15. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
16. Radinger M, Bossios A, Alm AS, et al. Regulation of allergen-induced bone marrow eosinophilopoiesis: role of CD4+ and CD8+ T cells. Allergy 2007; 62: 1410-1418.
17. Wills-Karp M,. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 2004; 202: 175-190.
18. Qiu D, Kao PN,. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R. D. 2003; 4: 1-18.
19. Andrews AL, Bucchieri F, Arima K, et al. Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q. J. Allergy Clin. Immunol. 2007; 120: 91-97.
20. Wills-Karp M,. The gene encoding interleukin-13: a susceptibility locus for asthma and related traits. Respir. Res. 2000; 1: 19-23.
21. Usmani OS, Ito K, Maneechotesuwan K, et al. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am. J. Respir. Crit. Care Med. 2005; 172: 704-712.
22. Maneechotesuwan K, Yao X, Ito K, et al. Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. Plos Med. 2009; 6: e1000076.
23. Ito K, Jazrawi E, Cosio B, et al. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J. Biol. Chem. 2001; 276: 30208-30215.
24. Ito K, Barnes PJ, Adcock IM,. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 2000; 20: 6891-6903.
25. Hogan MB, Piktel D, Landreth KS,. IL-5 production by bone marrow stromal cells: implications for eosinophilia associated with asthma. J. Allergy Clin. Immunol. 2000; 106: 329-336.
26. Vladich FD, Brazille SM, Stern D, et al. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J. Clin. Invest. 2005; 115: 747-754.
27. Zhang J, Pare PD, Sandford AJ,. Recent advances in asthma genetics. Respir. Res. 2008; 9: 4-11.
28. Webb DC, Matthaei KI, Cai Y, et al. Polymorphisms in IL-4R alpha correlate with airways hyperreactivity, eosinophilia, and Ym protein expression in allergic IL-13-/- mice. J. Immunol. 2004; 172: 1092-1098.
29. Fulkerson PC, Fischetti CA, Hassman LM, et al. Persistent effects induced by IL-13 in the lung. Am. J. Respir. Cell Mol. Biol. 2006; 35: 337-346.
30. Kasaian MT, Tan XY, Jin M, et al. Interleukin-13 neutralization by two distinct receptor blocking mechanisms reduces immunoglobulin E responses and lung inflammation in cynomolgus monkeys. J. Pharmacol. Exp. Ther. 2008; 325: 882-892.
31. Hogan PG, Chen L, Nardone J, et al. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17: 2205-2232.